Term ends Apr 27, 2031 · High confidence
20-year base term ends Apr 27, 2031
Held by Sorrento Therapeutics, Inc.
Filed Apr 27, 2011 as application 13/095,489 · Granted Apr 2, 2019
Base term plus 1215 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2011
2031
Clock starts
Apr 27, 2011
Apr 27, 2011
Term ends
Apr 27, 2031
Apr 27, 2031
Granted
Apr 2, 2019
Apr 2, 2019
base term
fee events
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,215
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,029,082, US 10,029,083, US 10,029,084, US 9,522,262, US 9,522,263, US 9,526,883, US 9,545,507, US 9,550,053.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
76
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 1215 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 27, 2011, when this application, 13/095,489, was filed | Apr 27, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1215 days, USPTO patent term adjustment record | Aug 24, 2034 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,029,082, US 10,029,083, US 10,029,084, US 9,522,262, US 9,522,263, US 9,526,883, US 9,545,507, US 9,550,053) | capped to Apr 27, 2031 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 27, 2031 | High confidence |
Partial family
| US 8,696,637 | Lapsed on the fee record Apr 2026 | Apr 2026 |
| US 10,245,421 | this patent Apr 2031 | Apr 2031 |
| Application PCT/IB2011/051860 | PCT application no patent term | no patent term |
| Application PCT/IB2011/051861 | PCT application no patent term | no patent term |
| Application PCT/IB2011/051862 | PCT application no patent term | no patent term |
| Application PCT/IB2011/051863 | PCT application no patent term | no patent term |
| Application PCT/IB2011/051864 | PCT application no patent term | no patent term |
| US 8,636,696 | Lapsed on the fee record Jan 2026 | Jan 2026 |
8 of 76 applications in this family shown, earliest filings first. Partial: 11 of the 76 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 11, 2011 Reel 26570, frame 28 | Ross, Russell Frederick | Kimberly-Clark Worldwide, Inc. | Assignment of Assignor's Interest |
| Feb 3, 2015 Reel 34880, frame 634 | Kimberly-Clark Worldwide, Inc. | Kimberly-Clark Worldwide, Inc. | Name Change |
| Sep 18, 2018 Reel 46899, frame 689 | Kimberly-Clark Worldwide, Inc. | Sorrento Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 7, 2018 Reel 47446, frame 335 | Sorrento Therapeutics, Inc.; TNK Therapeutics, Inc.; Concortis Biosystems, Corp.; Ark Animal Health, Inc.; Scintilla Pharmaceuticals, Inc. | Oaktree Fund Administration, LLC | Security Interest |
| Jul 31, 2020 Reel 53368, frame 577 | Oaktree Fund Administration, LLC | Sorrento Therapeutics, Inc.; TNK Therapeutics, Inc.; Concortis Biosystems, Corp.; Ark Animal Health, Inc.; Scintilla Pharmaceuticals, Inc. | Release of Security Interest |
| Jul 31, 2020 reel/frame not recorded | Oaktree Fund Administration, LLC | Sorrento Therapeutics, Inc. | Release of Security Interest |
| Jul 31, 2020 reel/frame not recorded | Oaktree Fund Administration, LLC | TNK Therapeutics, Inc. | Release of Security Interest |
| Jul 31, 2020 reel/frame not recorded | Oaktree Fund Administration, LLC | Concortis Biosystems, Corp. | Release of Security Interest |
| Jul 31, 2020 reel/frame not recorded | Oaktree Fund Administration, LLC | Ark Animal Health, Inc. | Release of Security Interest |
| Jul 31, 2020 reel/frame not recorded | Oaktree Fund Administration, LLC | Scintilla Pharmaceuticals, Inc. | Release of Security Interest |
| Apr 6, 2023 Reel 63283, frame 63 | Sorrento Therapeutics, Inc.; Scintilla Pharmaceuticals, Inc. | JMB Capital Partners Lending, LLC | Security Interest |
| Jul 31, 2023 Reel 64441, frame 575 | Sorrento Therapeutics, Inc.; Scintilla Pharmaceuticals, Inc. | Scilex Holding Company | Security Interest |
| Aug 11, 2023 Reel 64571, frame 848 | JMB Capital Partners Lending, LLC | Sorrento Therapeutics, Inc.; Scintilla Pharmaceuticals, Inc. | Release of Security Interest |
| Aug 11, 2023 reel/frame not recorded | JMB Capital Partners Lending, LLC | Sorrento Therapeutics, Inc. | Release of Security Interest |
| Aug 11, 2023 reel/frame not recorded | JMB Capital Partners Lending, LLC | Scintilla Pharmaceuticals, Inc. | Release of Security Interest |
| Sep 21, 2023 Reel 65017, frame 844 | Scilex Holding Company | Sorrento Therapeutics, Inc.; Scintilla Pharmaceuticals, Inc. | Termination and Release of Security Interest in Intellectual Property |
| Sep 21, 2023 reel/frame not recorded | Scilex Holding Company | Sorrento Therapeutics, Inc. | Termination and Release of Security Interest in Intellectual Property |
| Sep 21, 2023 reel/frame not recorded | Scilex Holding Company | Scintilla Pharmaceuticals, Inc. | Termination and Release of Security Interest in Intellectual Property |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2031
Term ends Apr 27, 2031.
Note
The 1215 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 10,029,082, US 10,029,083, US 10,029,084, US 9,522,262, US 9,522,263, US 9,526,883, US 9,545,507, US 9,550,053.
Citations
56
later US patents cite this one
That is top 5% of utility patents granted in 2019 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.